Characteristics of ceftibuten uptake into Caco-2 cells. 1994

N Muranushi, and K Horie, and K Masuda, and K Hirano
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.

The characteristics of ceftibuten uptake into Caco-2 cells grown in a collagen-coated dish were examined. Ceftibuten showed stereoselective and pH-dependent uptake. The pH-dependency of ceftibuten was more marked than that of cefaclor or cephalexin, but all three antibiotics showed maximal uptake at pH 5.5. Ceftibuten uptake was linear for the initial 1 hr and then reached a plateau. The initial uptake (15 min) was markedly reduced by the addition of 2,4-dinitrophenol or FCCP (a protonophore), or by lowering the incubation temperature. The uptake of ceftibuten into the brush-border membrane vesicles prepared from cultured Caco-2 cells showed an overshoot in the presence of an H(+)-gradient. These findings indicated that the uptake of ceftibuten was energy-dependent, especially H(+)-gradient-dependent. Uptake inhibition by various compounds was compared using Caco-2 cells. Amino acids and a tetrapeptide did not inhibit uptake, whereas di- or tri-peptides were effective inhibitors. These observations suggest that ceftibuten is taken up by a carrier-mediated transport system(s) for dipeptides. Various antibiotics differed in their ability to inhibit uptake, with cyclacillin showing maximum inhibition. Differences in the inhibitory effect may be accounted for by the heterogeneity (multiplicity) of the transport systems.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008871 Microvilli Minute projections of cell membranes which greatly increase the surface area of the cell. Brush Border,Striated Border,Border, Brush,Border, Striated,Borders, Brush,Borders, Striated,Brush Borders,Microvillus,Striated Borders
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004140 Dinitrophenols Organic compounds that contain two nitro groups attached to a phenol.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000077722 Ceftibuten A cephalosporin antibacterial agent that is used in the treatment of infections, including urinary-tract and respiratory-tract infections. 7-(2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid,7432 S,7432-S,Cedax,SCH 39720,SCH-39720,SCH39720
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

N Muranushi, and K Horie, and K Masuda, and K Hirano
November 2002, Biopharmaceutics & drug disposition,
N Muranushi, and K Horie, and K Masuda, and K Hirano
March 2018, Food research international (Ottawa, Ont.),
N Muranushi, and K Horie, and K Masuda, and K Hirano
January 2014, Biological & pharmaceutical bulletin,
N Muranushi, and K Horie, and K Masuda, and K Hirano
September 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
N Muranushi, and K Horie, and K Masuda, and K Hirano
December 2010, Journal of agricultural and food chemistry,
N Muranushi, and K Horie, and K Masuda, and K Hirano
September 2009, Toxicology letters,
N Muranushi, and K Horie, and K Masuda, and K Hirano
January 1995, Biochemical and biophysical research communications,
N Muranushi, and K Horie, and K Masuda, and K Hirano
October 2003, Biopharmaceutics & drug disposition,
N Muranushi, and K Horie, and K Masuda, and K Hirano
April 2002, Bioscience, biotechnology, and biochemistry,
Copied contents to your clipboard!